From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Andrew Monk Disgrace Dispensa: will it (again) restate its interims before insolvency?

By Tom Winnifrith | Wednesday 17 January 2024


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Dispensa (DISP) the Sub Standard list POS formerly known as Zamaz, a company created by Dominic White of the fraud Supply@ME Capital (SYME) infamy is in serious trouble. The only question now is when the end will come and why. This company listed at 11p, a £77million market cap in September 2022. I explicitly warned that it was a sham but the FCA knew better and allowed the listing to go ahead. The shares are now just 1.625p and my target is 0p.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VANL

Van Elle Holdings – a Buy?

Thursday »

CCT

Character Group – a Buy?

 

ING

Ingenta – now a Buy again?

 

Clown

Which PR genius wrote this?

Time left: 09:09:48